A Clinical Study of iEPC Intervent Subjects With Cerebral Hemorrhagic Stroke

Clinical trial NCT03726814 · UNKNOWN

Trial details

NCT number: NCT03726814
Sponsor: Allife Medical Science and Technology Co., Ltd.
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Stroke, Ischemic

Start date: 2018-12-01
Primary completion: 2018-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.